Merck's Bid To Block Expert Testimony Mostly Fails
The judge in charge of the multidistrict litigation over the osteoporosis drug Fosamax has rejected Merck & Co.'s bid to exclude three experts' general causation testimony, but granted the drugmaker's bid...To view the full article, register now.
Already a subscriber? Click here to view full article